110 related articles for article (PubMed ID: 8030558)
1. Comparative efficacy of androgen analogues in suppressing lacrimal gland inflammation in a mouse model (MRL/lpr) of Sjögren's syndrome.
Rocha FJ; Sato EH; Sullivan BD; Sullivan DA
Adv Exp Med Biol; 1994; 350():697-700. PubMed ID: 8030558
[No Abstract] [Full Text] [Related]
2. Impact of androgen therapy in Sjögren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice.
Sato EH; Ariga H; Sullivan DA
Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2537-45. PubMed ID: 1634351
[TBL] [Abstract][Full Text] [Related]
3. Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome.
Sullivan DA; Edwards JA
J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):237-45. PubMed ID: 9191982
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL/Mp-lpr/lpr mouse model of Sjögren's syndrome.
Ono M; Rocha FJ; Sullivan DA
Exp Eye Res; 1995 Dec; 61(6):659-66. PubMed ID: 8846837
[TBL] [Abstract][Full Text] [Related]
5. Ca2+ signaling by cholinergic and alpha1-adrenergic agonists is up-regulated in lacrimal and submandibular glands in a murine model of Sjögren's syndrome.
Zoukhri D; Hodges RR; Rawe IM; Dartt DA
Clin Immunol Immunopathol; 1998 Nov; 89(2):134-40. PubMed ID: 9787115
[TBL] [Abstract][Full Text] [Related]
6. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren's syndrome.
Sato EH; Sullivan DA
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2632-42. PubMed ID: 8163351
[TBL] [Abstract][Full Text] [Related]
7. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
[TBL] [Abstract][Full Text] [Related]
8. Lacrimal gland innervation is not altered with the onset and progression of disease in a murine model of Sjögren's syndrome.
Zoukhri D; Hodges RR; Dartt DA
Clin Immunol Immunopathol; 1998 Nov; 89(2):126-33. PubMed ID: 9787114
[TBL] [Abstract][Full Text] [Related]
9. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.
Zoukhri D; Kublin CL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):925-32. PubMed ID: 11274068
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
11. Androgen control of autoimmune expression in lacrimal glands of MRL/Mp-lpr/lpr mice.
Ariga H; Edwards J; Sullivan DA
Clin Immunol Immunopathol; 1989 Dec; 53(3):499-508. PubMed ID: 2805454
[TBL] [Abstract][Full Text] [Related]
12. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
[TBL] [Abstract][Full Text] [Related]
13. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
Jabs DA; Enger C; Prendergast RA
Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
[TBL] [Abstract][Full Text] [Related]
14. Presence and testosterone influence on the levels of anti- and pro-inflammatory cytokines in lacrimal tissues of a mouse model of Sjögren's syndrome.
Rocha EM; Wickham LA; Huang Z; Toda I; Gao J; da Silveira LA; Sullivan DA
Adv Exp Med Biol; 1998; 438():485-91. PubMed ID: 9634925
[No Abstract] [Full Text] [Related]
15. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
[TBL] [Abstract][Full Text] [Related]
16. Androgen-induced suppression of autoimmune disease in lacrimal glands of mouse models of Sjögren's syndrome.
Sullivan DA; Ariga H; Vendramini AC; Rocha FJ; Ono M; Sato EH
Adv Exp Med Biol; 1994; 350():683-90. PubMed ID: 8030556
[No Abstract] [Full Text] [Related]
17. Gender and androgen treatment influence the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice.
Toda I; Wickham LA; Sullivan DA
Clin Immunol Immunopathol; 1998 Jan; 86(1):59-71. PubMed ID: 9434797
[TBL] [Abstract][Full Text] [Related]
18. Dry eye management in a Sjögren's syndrome mouse model by inhibition of p38-MAPK pathway.
Ma X; Zou J; He L; Zhang Y
Diagn Pathol; 2014 Jan; 9():5. PubMed ID: 24443980
[TBL] [Abstract][Full Text] [Related]
19. Testosterone Influence on Gene Expression in Lacrimal Glands of Mouse Models of Sjögren Syndrome.
Morthen MK; Tellefsen S; Richards SM; Lieberman SM; Rahimi Darabad R; Kam WR; Sullivan DA
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2181-2197. PubMed ID: 31108549
[TBL] [Abstract][Full Text] [Related]
20. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
